මාස 3 සැලැස්ම - අශ්වගන්ධා පවර් පැක්
A 90-day Ashwagandha routine, three bottles in one box
Last updated: June 2026
The Ashwagandha Power Pack is a 90-day supply of our Ashwagandha, three full-size bottles in one box at a better price than buying them one at a time. A daily adaptogen for stress, sleep and steady energy that builds over the weeks.
What is inside
Three bottles of Ashwagandha (Withania somnifera) capsules, 60 capsules each, for a full 90 days. The same Ashwagandha you would buy on its own.
How to take it
Take 1 capsule with a meal, once or twice daily. Many people take it in the evening for sleep support, others in the morning for steady daytime energy. Suitable for a full 90 days, then a 1 to 2 week break.
Who it is for
Adults committing to a steady 90-day Ashwagandha routine for stress and sleep, athletes layering daily adaptogen support alongside training, and anyone with a high daily stress load who wants support that compounds over weeks.
Important safety note
Speak with your doctor before starting if you are pregnant, on thyroid medication, or taking sedatives.
Quality
Made in Sri Lanka under BRCGS, GMP, HACCP, FSSC 22000 and ISO 22000. Vegetarian capsules.
Calm & Clarity Protocol
Taken alongside
Is this right for you?
Ask Jivaka. It will tell you how මාස 3 සැලැස්ම - අශ්වගන්ධා පවර් පැක් fits your routine, the right dose and timing, and whether something simpler should come first.
ඔබ ද කැමති හැක
බ්ලොග් සටහන්
Gurmar and Sweet Taste: What the Bitter Leaf Really Does
Gymnemic acids block the human sweet taste receptor on the tongue. Here is what a 12 week trial of 600 mg a day found, and how long a course should run.
5 Mistakes Behind Late Afternoon Cravings, and How to Fix Them
Late afternoon cravings are not a willpower problem. Three nights of 5-hour sleep raised preferred sugar concentration from 12.9% to 20.9% in one trial. Five mistakes that build the 4 PM craving, a...
Venivel: What the Yellow Vine Is, and What We Actually Know
Venivel is the third herb in Ancient Nutra's Sugar Balance System. PubMed holds 49 papers on it and zero human trials, and the vine itself is in steep decline.